Development of a model‐based clinical trial simulation platform to optimize the design of clinical trials for Duchenne muscular dystrophy
Abstract Early clinical trials of therapies to treat Duchenne muscular dystrophy (DMD), a fatal genetic X‐linked pediatric disease, have been designed based on the limited understanding of natural disease progression and variability in clinical measures over different stages of the continuum of the...
Saved in:
Main Authors: | Karthik Lingineni (Author), Varun Aggarwal (Author), Juan Francisco Morales (Author), Daniela J. Conrado (Author), Diane Corey (Author), Camille Vong (Author), Jackson Burton (Author), Jane Larkindale (Author), Klaus Romero (Author), Stephan Schmidt (Author), Sarah Kim (Author), the Cooperative International Neuromuscular Research Group investigators and Duchenne Regulatory Science Consortium members (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multivariate modeling of magnetic resonance biomarkers and clinical outcome measures for Duchenne muscular dystrophy clinical trials
by: Sarah Kim, et al.
Published: (2023) -
Clinical-evolutionary considerations in Duchenne Dystrophy
by: Cristina Elena Singer, et al.
Published: (2023) -
Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (1989) -
Prednisone in Duchenne Dystrophy
by: J Gordon Millichap
Published: (1991) -
Standardized Data Structures in Rare Diseases: CDISC User Guides for Duchenne Muscular Dystrophy and Huntington's Disease
by: Ariana P. Mullin, et al.
Published: (2021)